Enhanced FGF21 Delivery via Neutrophil-Membrane-Coated Nanoparticles Improves Therapeutic Efficacy for Myocardial Ischemia-Reperfusion Injury.

Rao, Zhiheng et al.·Nanomaterials (Basel·2025·low-moderateAnimal StudyAnimal Study
RPEP-13204Animal Studylow-moderate2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
low-moderate
Sample
N=Not specified (animal study)
Participants
Mice with ischemia-reperfusion cardiac injury

What This Study Found

Neutrophil-membrane-coated nanoparticles loaded with FGF21 reduced heart damage after ischemia-reperfusion in mice by targeting inflamed cardiac tissue.

Key Numbers

Neutrophil-membrane coated liposomal NPs with FGF21; tested in mouse ischemia-reperfusion model; improved cardiac outcomes vs uncoated NPs.

How They Did This

Nanoparticle fabrication, neutrophil membrane coating, characterization, and in vivo testing in mouse I/R injury model.

Why This Research Matters

FGF21 is a metabolic regulator (like GLP-1 drugs) that protects the heart. Wrapping it in neutrophil membranes helps it reach damaged heart tissue more effectively.

What This Study Doesn't Tell Us

Mouse model. Complex manufacturing process. Long-term safety of neutrophil-coated particles unknown. FGF21 may have off-target effects.

Trust & Context

Original Title:
Enhanced FGF21 Delivery via Neutrophil-Membrane-Coated Nanoparticles Improves Therapeutic Efficacy for Myocardial Ischemia-Reperfusion Injury.
Published In:
Nanomaterials (Basel, Switzerland), 15(5) (2025)
Database ID:
RPEP-13204

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Read More on RethinkPeptides

Cite This Study

RPEP-13204·https://rethinkpeptides.com/research/RPEP-13204

APA

Rao, Zhiheng; Tang, Yuli; Zhu, Jiamei; Lu, Zhenzhen; Chen, Zhichao; Wang, Jiaojiao; Bao, Yuxuan; Mukondiwa, Alan Vengai; Wang, Cong; Wang, Xiaojie; Luo, Yongde; Li, Xiaokun. (2025). Enhanced FGF21 Delivery via Neutrophil-Membrane-Coated Nanoparticles Improves Therapeutic Efficacy for Myocardial Ischemia-Reperfusion Injury.. Nanomaterials (Basel, Switzerland), 15(5). https://doi.org/10.3390/nano15050346

MLA

Rao, Zhiheng, et al. "Enhanced FGF21 Delivery via Neutrophil-Membrane-Coated Nanoparticles Improves Therapeutic Efficacy for Myocardial Ischemia-Reperfusion Injury.." Nanomaterials (Basel, 2025. https://doi.org/10.3390/nano15050346

RethinkPeptides

RethinkPeptides Research Database. "Enhanced FGF21 Delivery via Neutrophil-Membrane-Coated Nanop..." RPEP-13204. Retrieved from https://rethinkpeptides.com/research/rao-2025-enhanced-fgf21-delivery-via

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.